ロード中...
In vivo Environment Swiftly Restricts Human Pancreatic Progenitors Toward Mono-Hormonal Identity via a HNF1A/HNF4A Mechanism
Generating insulin-producing β-cells from human induced pluripotent stem cells is a promising cell replacement therapy for improving or curing insulin-dependent diabetes. The transplantation of end-stages differentiating cells into living hosts was demonstrated to improve β-cell maturation. Neverthe...
保存先:
| 出版年: | Front Cell Dev Biol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7052484/ https://ncbi.nlm.nih.gov/pubmed/32161757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.00109 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|